| Hudson Investment Group Limited (HGL) ORDINARY FULLY PAID |
Real Estate |
- |
Quarterly Report and Activity Statement
|
30 Jul 2025 9:04AM |
$0.175 |
$0.175 |
fallen by
0%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$41 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 9:03AM |
$0.024 |
$0.033 |
risen by
37.50%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported quarterly activities and Appendix 4C Cash Flow for the quarter ending 30 June 2023.
- Achieved growth in annual recurring revenue from SaaS subscription sales.
- Expanded into new markets and continued product development.
- Focused on clinical and workplace solutions via wearable sensor technology.
- Delivered products through both direct and channel sales models.
- Received customer cash receipts and managed costs effectively.
- Secured grant funding to support business growth and innovation.
- Reported prudent cash flow management and maintained sufficient cash reserves.
- Provided a financial summary in line with ASX listing requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$29 |
Firebird to Develop Lithium Manganese Rich Cathode
|
30 Jul 2025 9:03AM |
$0.125 |
$0.160 |
risen by
28%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebird Metals Limited has developed a lithium-manganese-rich (LMR) cathode using its own supply chain.
- The LMR cathode was produced from battery-grade HPMSM sourced from Firebird’s wholly-owned subsidiary in China.
- The cathode material demonstrated high electrochemical performance and cycle stability.
- This innovation enables Firebird to target the expanding market for lithium-ion batteries, especially for EVs and energy storage.
- The LMR cathode is part of Firebird’s strategy to vertically integrate its battery materials business.
- Firebird has commenced pilot production runs and is working on scaling up manufacturing capabilities.
- The company is pursuing partnerships and market entry strategies in China and internationally.
- The announcement positions Firebird as a new player in the advanced battery materials sector with upstream supply chain control.
- Firebird’s LMR cathode development supports its goal of building a new energy material ecosystem.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 9:03AM |
$0.018 |
$0.013 |
fallen by
27.78%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- The company is advancing its portfolio of topical and transdermal pharmaceutical products.
- Acrux made regulatory submissions in the US and other markets during the quarter.
- Development of pipeline products remained a focus, with progress on multiple projects.
- The company maintained ongoing relationships with commercial and development partners.
- Cash flow summary included research and development expenses, receipts from customers, and other operating costs.
- Acrux reported its cash position and financial outlook remains stable.
- The company continues to focus on regulatory milestones and commercial expansion.
- Management is committed to prudent financial management as it seeks to grow its diversified pharmaceutical portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$86 |
IONIC TECH TO RAMP UP HREO TO SUPPLY REQUESTS FROM MAJORS
|
30 Jul 2025 9:01AM |
$0.021 |
$0.380 |
risen by
1,709.52%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ionic Technologies (IonicTech) is scaling up the production of separated magnet rare earth oxides (NdPr, Dy, Tb) at its Belfast facility.
- Production ramp-up is in response to direct supply requests from major manufacturers and OEMs in the automotive and energy sectors.
- The process utilizes recycled end-of-life permanent magnets, contributing to circular economy and sustainability goals.
- IonicTech’s proprietary recycling technology enables the production of high-purity rare earth oxides required for EVs, wind turbines, and electronics.
- The company is actively engaged with various global partners for product qualification and potential off-take agreements.
- Ionic Rare Earths Limited highlights the importance of Western supply chain security for critical minerals, particularly amid geopolitical tensions.
- Progress has been made on customer qualification batches, with increasing volumes requested by automotive and other major customers.
- The company’s strategy includes integrating recycling capacity with its Makuutu rare earths project for a comprehensive supply solution.
- IonicTech’s products address industry needs for traceability, reduced carbon footprint, and compliance with emerging environmental regulations.
- This announcement positions IXR as a key supplier of sustainable, recycled, and traceable rare earth oxides critical to advanced manufacturing and green technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$32 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:00AM |
$1.100 |
$0.440 |
fallen by
60%
|
|
LKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lakes Blue Energy NL provided its quarterly activities and cash flow report for the period ending 31 March 2024.
- Otway Basin project activities included ongoing regulatory engagement and farm-in discussions for the Lake Purdie project.
- The GOR acquisition remains suspended, pending resolution of legal proceedings.
- The company is evaluating new exploration opportunities, particularly in the Cooper Basin.
- A significant capital raising was completed during the quarter, with strong support from major shareholders and directors.
- The company continues to manage legal proceedings relevant to its operations.
- The Appendix 5B cash flow statement shows a positive cash balance at the end of the period.
- Corporate priorities include advancing existing projects and exploring growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CZR Resources Ltd (CZR) ORDINARY FULLY PAID |
Materials |
$48 |
Strong Conductors identified at Edamurta Copper Project
|
30 Jul 2025 9:00AM |
$0.250 |
$0.200 |
fallen by
20%
|
|
CZR - Price-sensitive ASX Announcement
Full Release
Key Points
- CZR Resources Ltd completed a ground electromagnetic survey at Edamurta Copper Project.
- Survey identified several strong conductors interpreted as potential copper-nickel sulphide mineralization.
- Multiple priority targets for drill testing have been defined.
- The Edamurta Project is located in the West Musgrave belt, a prospective region for large-scale base metal deposits.
- Conductors are situated near major structural features, enhancing their mineralization potential.
- Planned follow-up drilling to test the strongest EM targets in 2024.
- The project is positioned as a key exploration focus for CZR Resources Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$91 |
Update - Notification of buy-back - TOP
|
30 Jul 2025 8:59AM |
$0.650 |
$0.540 |
fallen by
16.92%
|
|
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$37 |
Quarterly Activities Report
|
30 Jul 2025 8:59AM |
$0.078 |
$0.115 |
risen by
47.44%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ongoing exploration and drilling at Ilo Este and Ilo Norte copper projects in Southern Peru.
- Positive initial drill results and future exploration plans announced.
- Progress reported at Jaguar Lithium Project in Brazil.
- Advancement of Cubiro Copper Project in Peru.
- Corporate updates include successful capital raising and board changes.
- Financial summary shows cash position and expenditure details.
- Focus on expanding and developing copper and lithium asset portfolio in South America.
- Emphasis on delivering shareholder value through exploration and project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$24 |
NAOS Quarterly Investment Report - Q4 FY25
|
30 Jul 2025 8:59AM |
$0.490 |
$0.520 |
risen by
6.12%
|
|
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$29 |
NAOS Quarterly Investment Report - Q4 FY25
|
30 Jul 2025 8:59AM |
$0.290 |
$0.395 |
risen by
36.21%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$42 |
NAOS Quarterly Investment Report - Q4 FY25
|
30 Jul 2025 8:58AM |
$0.290 |
$0.320 |
risen by
10.34%
|
|
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,153 |
2Q25 Results Call
|
30 Jul 2025 8:58AM |
$2.960 |
$2.330 |
fallen by
21.28%
|
|
| Great Northern Minerals Limited (GNM) ORDINARY FULLY PAID |
Materials |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 8:57AM |
$0.019 |
$0.032 |
risen by
72.97%
|
|
GNM - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash balance of $1.29M as at 30 June 2025.
- Sale of 90% of Golden Ant Mining progressing, $1M expected upon completion of Phase 4.
- Ongoing evaluation of resource projects for potential acquisition.
- Golden Ant Earn-In Agreement involves GEG increasing its stake to 90%.
- Exploration and evaluation expenditure during the quarter was $10K.
- No mining production and development activities during the quarter.
- Payments to related parties totalled $101K during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Metals NL (FME) ORDINARY FULLY PAID |
Materials |
$15 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 8:57AM |
$0.017 |
$0.016 |
fallen by
5.88%
|
|
FME - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed successful drilling campaign at Panton PGM-Nickel Project confirming mineralisation continuity.
- Updated Mineral Resource Estimate highlighting growth potential.
- Advanced metallurgical testwork supporting project development studies.
- Progressed scoping study and permitting including environmental and heritage approvals.
- Continued stakeholder and community engagement activities.
- Monitored and reported on quarterly cash flows, including exploration, staff, and administration costs.
- Maintained sufficient cash reserves for ongoing activities.
- Engaged in strategic discussions with potential partners and investors for project advancement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$74 |
Quarterly Activities and Cashflow Report
|
30 Jul 2025 8:57AM |
$0.041 |
$0.045 |
risen by
9.76%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- Ongoing exploration at Hamilton Copper Project in northwest Queensland, with drilling targeting copper mineralization.
- Progress at Balladonia Base Metal Project in Western Australia, including geophysical surveys and new target identification.
- Peru Joint Venture (JV) with South32 continued, focusing on porphyry copper targets in southern Peru with drilling and field programs.
- Cash inflows included government incentives and JV funding contributions.
- Cash outflows mainly comprised exploration and evaluation expenditures, administration, and staff costs.
- The company ended the quarter with a cash balance sufficient for ongoing exploration activities.
- No mining production or development activities were reported during the quarter.
- AusQuest continues to prioritize new project generation and partnerships to advance its exploration portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$40 |
Findi Completes Successful Pilot of BC Max Centres
|
30 Jul 2025 8:56AM |
$3.950 |
$0.405 |
fallen by
89.75%
|
|
FND - Price-sensitive ASX Announcement
Full Release
Key Points
- Findi Limited (FND) completed a successful pilot of BC Max Centres in India.
- The pilot was conducted in partnership with the State Bank of India.
- BC Max Centres provide banking, insurance, and digital payment services to underserved and rural areas.
- The pilot exceeded key operational and transaction volume targets.
- Findi Limited plans to expand the BC Max Centre network following the success of the pilot.
- The initiative supports financial inclusion and accessibility in India.
- The announcement was made on 27 February 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Auris Minerals Limited (AUR) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 8:55AM |
$0.006 |
$0.016 |
risen by
166.67%
|
|
AUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Auris Minerals Limited focused on copper and gold exploration in the Bryah Basin during the quarter.
- Field activities included drill programs at Forrest and Wodger prospects.
- Joint venture projects with Sandfire Resources and Develop Global progressed, with further exploration planned.
- Other project areas like Feather Cap, Cashmans, and Morck Well received geological review and planning.
- The company had a solid cash position at the end of the quarter.
- Quarterly expenditures mainly comprised exploration, staff, and administrative costs.
- Cost management remains a company priority.
- Disclosures on payments to directors and related parties are included as per ASX Listing Rules.
- Appendix 5B provides a detailed quarterly cashflow statement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$138 |
Quarterly Activities and Cashflow Reports
|
30 Jul 2025 8:55AM |
$0.155 |
$0.270 |
risen by
74.19%
|
|
FXG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for the period ending 31 March 2024.
- Exploration focused on the Fairbanks Gold District in Alaska.
- Infill drilling at NW Array delivered promising gold results.
- Discovery and advancement at the Scrafford Shear prospect.
- Ongoing soil sampling, mapping, and geophysical work across multiple targets.
- Operational achievements include efficient fieldwork and data integration.
- Permitting and environmental initiatives are progressing as planned.
- Cash balance and financial position disclosed, with prudent management of exploration expenditure.
- Active engagement with potential partners and stakeholders.
- Future drilling campaigns and project advancements are planned, contingent on market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$115 |
Actinogen June 2025 quarterly activity report & Appendix 4C
|
30 Jul 2025 8:55AM |
$0.026 |
$0.031 |
risen by
19.23%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress of Xanamem® clinical trials in Alzheimer's disease and depression
- Updates on study recruitment, interim analyses, and upcoming milestones
- Financial results, cash flow statement, and R&D expenditure for the quarter
- Strategic business development priorities and future outlook
- Commitment to advancing neurological disease treatments
- Comprehensive overview of operational, clinical, and financial activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$5,822 |
Change in substantial holding
|
30 Jul 2025 8:54AM |
$2.640 |
$3.070 |
risen by
16.29%
|
|
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,153 |
July 2025 Investor Presentation
|
30 Jul 2025 8:54AM |
$2.960 |
$2.330 |
fallen by
21.28%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield focuses on counterdrone technology amid rising global defense spending.
- AI and electronic countermeasures are central to their product offerings.
- Significant market opportunity with low industry saturation.
- Smart jamming and multi-sensor systems are key components of their technology.
- Substantial growth in revenue and sales pipeline projected.
- Plans for expansion in Europe and the US.
- Leadership team prioritizes innovation and strategic growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,153 |
July 2025 Investor Presentation
|
30 Jul 2025 8:54AM |
$2.960 |
$2.330 |
fallen by
21.28%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield Limited's revenue increased by 210% in HY2025 compared to HY2024.
- SaaS revenue for DroneShield is up by 177%.
- The sales pipeline is valued at $2.33 billion as of July 2025.
- DroneShield has a cash balance of $192.0 million as of July 24, 2025.
- The company is focusing on AI-powered SaaS solutions for enhanced detection and response to drones.
- DroneShield plans to expand its portfolio to include civilian markets.
- There is a strategic emphasis on regional manufacturing and sales hubs in Europe and the U.S.
- The company is investing over $50 million annually in R&D.
- DroneShield is poised to capitalize on a $10 billion+ total addressable market (TAM) for counter-drone technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$110 |
Almonty Appoints Brian Fox as Chief Financial Officer
|
30 Jul 2025 8:54AM |
$5.350 |
$23.430 |
risen by
337.94%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$191 |
Q4 FY25 Quarterly Activities Report and Appendix 4C
|
30 Jul 2025 8:53AM |
$1.600 |
$3.100 |
risen by
93.75%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitrafy continued commercial roll-out of its pharmaceutical cold chain technology.
- Signed a multi-year agreement with CSL Seqirus for vaccine manufacturing applications.
- Advanced commercial discussions with other global pharmaceutical companies.
- Ongoing R&D and regulatory progress supporting new product development.
- Strengthened intellectual property portfolio with additional patent applications.
- Improved product and supply chain readiness ahead of broader commercialization.
- Positive feedback and interest from global pharmaceutical and biotech companies.
- Ongoing ESG initiatives and engagement with stakeholders.
- Reported cash flows, funding status, and financial management.
- Board and management changes to support growth and commercialization strategy.
- Outlined key priorities for further commercial expansion and investment in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
